These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 33042799)

  • 1. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
    Tong T; Guan Y; Xiong H; Wang L; Pang J
    Front Oncol; 2020; 10():1541. PubMed ID: 33042799
    [No Abstract]   [Full Text] [Related]  

  • 2. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
    Nie D; Zhang L; Wang C; Guo Q; Mao X
    Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
    Zhang Y; Chen S; Chen H; Li W
    Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Xu S; Song L; Liu X
    Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
    Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
    Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
    Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
    Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis.
    Shim SR; Kim SJ; Kim SI; Cho DS
    World J Urol; 2017 May; 35(5):771-780. PubMed ID: 27665441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score.
    Hirahara N; Matsubara T; Kaji S; Kawabata Y; Hyakudomi R; Yamamoto T; Uchida Y; Ishitobi K; Takai K; Tajima Y
    Oncotarget; 2020 Nov; 11(45):4169-4177. PubMed ID: 33227100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis.
    Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis.
    Hu X; Wang Y; Yang WX; Dou WC; Shao YX; Li X
    Cancer Manag Res; 2019; 11():6163-6173. PubMed ID: 31308752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of modified Glasgow Prognostic Score in patients with non-metastatic clear cell renal cell carcinoma.
    Cho DS; Kim SI; Choo SH; Jang SH; Ahn HS; Kim SJ
    Scand J Urol; 2016 Jun; 50(3):186-91. PubMed ID: 26878156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
    Zhang H; Ren D; Jin X; Wu H
    Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting outcomes of Lung Cancer using the modified glasgow prognostic score: A systematic review and meta-analysis.
    Min Y; Li X; Chen H; Xu Y; Lan G
    Pak J Med Sci; 2024; 40(3Part-II):534-543. PubMed ID: 38356845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis.
    Yang C; Ren G; Yang Q
    Front Surg; 2022; 9():1094973. PubMed ID: 36700011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of modified Glasgow Prognostic Score in non-muscle-invasive bladder cancer.
    Kimura S; D' Andrea D; Soria F; Foerster B; Abufaraj M; Vartolomei MD; Iwata T; Karakiewicz PI; Rink M; Gust KM; Egawa S; Shariat SF
    Urol Oncol; 2019 Mar; 37(3):179.e19-179.e28. PubMed ID: 30580906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.